Large gap with delayed quotes
Analysis date: 27.06.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 27.06.2025.
Interest
Weak
Weak
Two stars since 13.06.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 20.05.2025 at a price of 143.20.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 29.04.2025.
4wk Rel Perf
0.17%
0.17%
The four-week dividend-adjusted performance versus STOXX600 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 21.02.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 0.98%.
Mkt Cap in $bn
5.18
5.18
With a market capitalization between $2 & $8bn, KRONES is considered a mid-cap stock.
G/PE Ratio
1.31
1.31
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
10.95
10.95
The estimated PE is for the year 2027.
LT Growth
12.01%
12.01%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
11
11
Over the last seven weeks, an average of 11 analysts provided earnings per share estimates.
Dividend Yield
2.37%
2.37%
The twelve month estimated dividend yield represents 25.90% of earnings forecasts.
Beta
153
153
For 1% of index variation, the stock varies on average by 1.53%.
Correlation
0.81
0.81
80.60% of stock movements are explained by index variations.
Value at Risk
16.81
16.81
The value at risk is estimated at EUR 16.81. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002